title: Human African trypanosomiasis in Angola: clinical observations, treatment, and use of PCR for stage determination of early stage of the disease.
abstract: Biological and clinical observations are described for 224 patients infected by human African trypanosomiasis (HAT) in Angola in 2007 and 2008. Seven patients were initially classified in stage 1 (S1), 17 intermediate stage (IS) (WBC <20 lymphocytes/μl with absence of trypanosomes in cerebrospinal fluid (CSF) and no neurological signs), and 200 in stage 2 (S2). Out of 224 patients, 165 (73.6%) presented one or more neurological signs. During treatment with eflornithine, six deaths of S2 patients occurred, five of which were because of an encephalopathy syndrome. Nine patients were diagnosed with a relapse or suspected treatment failure during the follow-up: eight patients after treatment with eflornithine (relapse rate 4.1%) and one patient after pentamidine (6.6%). The contribution of PCR for stage determination evaluated for S1 and IS confirms the difficulty of stage determination, as one S1 patient and two IS patients were carriers of trypanosomes detected a posteriori by PCR in CSF but were treated with pentamidine while follow-up did not confirm treatment efficacy. Since 2001 in Angola, either by passive or active mode detection, approximately 80% of the new cases every year were in S2, whereas the annual number of cases has regressed, probably because the transmission of HAT is decreasing. However, stage determination and treatment remain two major issues for the chronic form of sleeping sickness.
authors.affiliation: Institut de Recherche pour le Développement, Unité Mixte de Recherche 177 IRD-CIRAD, Campus International de Baillarguet, TA A17/G, 34398, Montpellier Cedex 5, France. Philippe.Truc@ird.fr
authors.forename: P
authors.initials: P
authors.lastname: Truc
authors.forename: A
authors.initials: A
authors.lastname: Lando
authors.forename: L
authors.initials: L
authors.lastname: Penchenier
authors.forename: G
authors.initials: G
authors.lastname: Vatunga
authors.forename: T
authors.initials: T
authors.lastname: Josenando
mesh_terms: D000328:Adult; D000810:Angola / Q000453:epidemiology; D000818:Animals; D000518:Eflornithine / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D021141:Nucleic Acid Amplification Techniques; D010419:Pentamidine / Q000627:therapeutic use*; D016133:Polymerase Chain Reaction; D012008:Recurrence; D012074:Remission Induction; D014344:Trypanocidal Agents / Q000627:therapeutic use*; D014347:Trypanosoma brucei gambiense / Q000235:genetics / Q000302:isolation & purification*; D014353:Trypanosomiasis, African / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000453:epidemiology
chemical_list: D014344:Trypanocidal Agents; D010419:Pentamidine; D000518:Eflornithine